Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis

被引:0
|
作者
Phyllis Chan
Jiajie Yu
Leslie Chinn
Marita Prohn
Jan Huisman
Brett Matzuka
William Hanley
Katie Tuckwell
Angelica Quartino
机构
[1] Clinical Pharmacology,Clinical Sciences
[2] qPharmetra,undefined
[3] qPharmetra,undefined
[4] Former Genentech employee,undefined
[5] currently of Seattle Genetics,undefined
[6] Early Clinical Development,undefined
关键词
Bruton’s tyrosine kinase (BTK) inhibitor; exposure-response; model-based meta-analysis; population pharmacokinetics; rheumatoid arthritis;
D O I
10.1007/s11095-019-2752-y
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 1: Binary Model)
    Li, Liang
    Zhang, Yi
    Ma, Lian
    Ji, Ping
    Yim, Sarah
    Chowdhury, Badrul
    Doddapaneni, Suresh
    Liu, Jiang
    Wang, Yaning
    Sahajwalla, Chandrahas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1097 - 1106
  • [42] Analysis of efficacy and safety of abatacept for rheumatoid arthritis: systematic review and meta-analysis
    Ahamada, M. Mohamed
    Wu, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (09) : 1882 - 1900
  • [43] Longitudinal exposure-response analysis of CDAI score in rheumatoid arthritis patients treated with sirukumab
    Xu, Yan
    Hu, Chuanpu
    Zhuang, Yanli
    Hsu, Benjamin
    Xu, Zhenhua
    Sharma, Amarnath
    Zhou, Honghui
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S121 - S121
  • [44] Model-based meta-analysis of salbutamol pharmacokinetics and practical implications for doping control
    Courlet, Perrine
    Buclin, Thierry
    Biollaz, Jerome
    Mazzoni, Irene
    Rabin, Olivier
    Guidi, Monia
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (04): : 469 - 481
  • [45] Population Pharmacokinetics and Exposure-Response Analysis of Entospletinib, a Selective Spleen Tyrosine Kinase Inhibitor
    Sharma, Shringi
    Jin, Feng
    He, Jing
    Robeson, Michelle
    Abella, Esteban
    Sharman, Jeff P.
    Ramanathan, Srini
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S79 - S79
  • [46] POPULATION PK AND EXPOSURE-RESPONSE ANALYSES OF APREMILAST IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS
    Kassir, N.
    Savant, I.
    Mouksassi, M. S.
    Marier, J. F.
    Zhu, W.
    Lau, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S90 - S90
  • [47] Population Pharmacokinetic and Exposure-Response Analyses of Apremilast in Subjects with Active Psoriatic Arthritis
    Liu, Yong
    Kassir, Nastya
    Mouksassi, Samer
    Zhou, Simon
    Marier, Jean-Francois
    Palmisano, Maria
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S34 - S35
  • [48] Population pharmacokinetics and exposure-response analysis of tigecycline in patients with hospital-acquired pneumonia
    Zhou, Yangang
    Xu, Ping
    Li, Huande
    Wang, Feng
    Yan, Han
    Liang, Wu
    Xiang, Daxiong
    Zhang, Bikui
    Banh, Hoan Linh
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (07) : 2838 - 2846
  • [49] Population Pharmacokinetics and Exposure-Response Analysis of Tribendimidine To Improve Treatment for Children with Hookworm Infection
    Brussee, Janneke M.
    Hiroshige, Noemi
    Neodo, Anna
    Coulibaly, Jean T.
    Pfister, Marc
    Keiser, Jennifer
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)
  • [50] Recurrent or progressive pediatric brain tumors: population pharmacokinetics and exposure-response analysis of pomalidomide
    Ogasawara, Ken
    Kassir, Nastya
    Wang, Xiaomin
    Benettaib, Bouchra
    Zhou, Simon
    Palmisano, Maria
    Li, Yan
    PEDIATRIC RESEARCH, 2021, 90 (04) : 832 - 839